SMFM Statement: Clarification of recommendations regarding cell-free DNA aneuploidy screening

The purpose of this statement is to clarify that SMFM does not recommend that cfDNA aneuploidy screening be offered to all pregnant women, nor does it suggest a requirement for insurance coverage for cfDNA screening in women at low-risk of aneuploidy.  However, SMFM believes due to the ethics of patient autonomy that the option should be available to women who request additional testing beyond what is currently recommended by professional societies.